Braden van der Wall and Steven Romanoff, allege that Illumina artificially inflated their stock price through misreporting the company’s earnings in Q3 2016.
New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.
The NIH has awarded inaugural funding to three institutions to establish a new genome centre for the All of Us Research Program.
The NIH has committed up to $45.5M to support its Somatic Cell Genome Editing programme. The money will make up a series of grants to be paid over the next four fiscal years.
US representatives are pressing genetic testing companies for details on their security systems and customer privacy policies.
Billionaire philanthropist Bill Gates has donated $30 million towards incentivising the development of an Alzheimer’s diagnostic test.
Verge Genomics, the drug discovery startup we recently featured in our Top 5 Startups Disrupting Healthcare, has raised $32 million in Series A financing.
Even in light of the rising fears of “superbugs” in the world of big pharma, the marginal profits made through the development of antibiotics isn’t enough to justify the research.
Founded in 1790, the Patent Office aimed to put innovation and entrepreneurship within reach of every citizen. Now, 10 million patents later, critics say an out-of-touch system is doing the opposite.